Psychedelic music

Global Psychedelic Therapeutics Market, 2020-2030

Retrieved on: 
Thursday, October 8, 2020
Hallucinations, Psychedelic drug, Psychedelic music

The "Global Psychedelic Therapeutics Market, 2020-2030" report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of psychedelic therapeutics, over the next decade.

Key Points: 
  • The "Global Psychedelic Therapeutics Market, 2020-2030" report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of psychedelic therapeutics, over the next decade.
  • - An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics, based on relevant parameters, such as type of psychedelic substance, trial phase, target therapeutic area and location of the trial.
  • In addition, it highlights popular psychedelic therapeutics, popular funding institute centers, prominent program officers, and popular recipient organizations.
  • One of the key objectives of the report was to estimate the existing market size and the future opportunity for psychedelic therapeutics, over the next decade.

"Days of Summer" - A timely, haunting, and memorable music soundtrack for this summer with elements of pop, folk, jazz and psychedelic rock by Indie Artist Will Diehl

Retrieved on: 
Tuesday, June 30, 2020
Counterculture of the 1960s, Psychedelic music, Psychedelic rock, Decades, Units of time

Diehl has won two Billboard songwriting awards, and has released over 20 albums, numerous EPS and singles.

Key Points: 
  • Diehl has won two Billboard songwriting awards, and has released over 20 albums, numerous EPS and singles.
  • In recent years, Diehl, a prolific writer of songs, has continued to focus on penning and recording original songs that are released digitally.
  • Musically, the new album "Days of Summer" provides a mix of jazz, pop, folk, and psychedelic rock.
  • Through the month of July, anyone who purchases music on willdiehl.com will gain full access to the Will Diehl Music Site subscription within 48 hours of purchase.

Psychedelic Drugs Market Projected to Reach $6.85 Billion by 2027

Retrieved on: 
Wednesday, June 24, 2020
Companies, AbbVie Inc., Allergan, Master of Medicine, Psychedelic drug, Psychedelic music, Health

NEW YORK, June 24, 2020 /PRNewswire/ -- The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to reach $6.8 5 billion by 2027 , according to Data Bridge Market Research.

Key Points: 
  • NEW YORK, June 24, 2020 /PRNewswire/ -- The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to reach $6.8 5 billion by 2027 , according to Data Bridge Market Research.
  • Meanwhile, Mota Ventures Corp. (OTCPK:PEMTF) (CSE:MOTA)is entering the psychedelic drug market through the acquisition of European psychedelic medicine company Verrian Ontario Ltd.
  • Even Big Pharma giant AbbVie Inc. (NYSE:ABBV)recently gained a stake in the psychedelic drugs market through the acquisition of Allergan PLC .
  • However, it appears that pure-play psychedelic medicine company Mind Medicine (MindMed) Inc. (NEO:MMED) (OTCQB:MMEDF) is a front-runner with multiple novel therapies moving through clinical trials.

Psychedelic Drugs Market Projected to Reach $6.85 Billion by 2027

Retrieved on: 
Wednesday, June 24, 2020
Companies, AbbVie Inc., Allergan, Master of Medicine, Psychedelic drug, Psychedelic music, Health

NEW YORK, June 24, 2020 /PRNewswire/ -- The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to reach $6.8 5 billion by 2027 , according to Data Bridge Market Research.

Key Points: 
  • NEW YORK, June 24, 2020 /PRNewswire/ -- The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to reach $6.8 5 billion by 2027 , according to Data Bridge Market Research.
  • Meanwhile, Mota Ventures Corp. (OTCPK:PEMTF) (CSE:MOTA)is entering the psychedelic drug market through the acquisition of European psychedelic medicine company Verrian Ontario Ltd.
  • Even Big Pharma giant AbbVie Inc. (NYSE:ABBV)recently gained a stake in the psychedelic drugs market through the acquisition of Allergan PLC .
  • However, it appears that pure-play psychedelic medicine company Mind Medicine (MindMed) Inc. (NEO:MMED) (OTCQB:MMEDF) is a front-runner with multiple novel therapies moving through clinical trials.

PSYC Launches Psychedelic Spotlight Website

Retrieved on: 
Thursday, May 28, 2020
Subcultures, Psychedelia, Underground culture, Psychedelic music

I am incredibly pleased and excited to unveil our Psychedelic Spotlight website to our shareholders and stakeholders and to take this very important step forward in ushering PSYC into the psychedelic market space, said Global Trac Solutions CEO, Vanessa Luna.

Key Points: 
  • I am incredibly pleased and excited to unveil our Psychedelic Spotlight website to our shareholders and stakeholders and to take this very important step forward in ushering PSYC into the psychedelic market space, said Global Trac Solutions CEO, Vanessa Luna.
  • This initial version of the Psychedelic Spotlight website is a mere representation of the foundation of what we intend to develop over the next several months.
  • PSYC is truly determined to position itself at the very forefront of the psychedelic movement and to bring together its growing community of advocates and scientific researchers through our Psychedelic Spotlight platform.
  • The Company intends to continue its development of the Psychedelic Spotlight website over the next several weeks adding additional news, research, and market analysis content in addition to original content focused on industry commentary and perspective.

Shifting Attitudes Towards Mental Health Open Doors to Innovative New Therapies

Retrieved on: 
Wednesday, April 29, 2020
Entheogens, Psychoactive drugs, Hallucinations, Articles, Drug culture, Novartis, Psychedelic drugs, Psilocybin, Hallucinogen, N,N-Dimethyltryptamine, Psychedelic music, Cannabis and religion

BDSA projects that U.S. legal cannabis sales will approach USD 34 Billion by 2025, increasing at an 18% CAGR.

Key Points: 
  • BDSA projects that U.S. legal cannabis sales will approach USD 34 Billion by 2025, increasing at an 18% CAGR.
  • The most commonly used psychedelic compounds are psilocybin (originated in mushrooms), LSD (lysergic acid diethylamide), DMT (dimethyltryptamine), and mescaline.
  • Last year, the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine has been launched and attracted investors as well as private donors.
  • Developing PSYC into a trusted resource marketplace for medicinal psychedelics is a multi-stage project that we have just initiated.

Shifting Attitudes Towards Mental Health Open Doors to Innovative New Therapies

Retrieved on: 
Wednesday, April 29, 2020
Entheogens, Psychoactive drugs, Hallucinations, Articles, Drug culture, Novartis, Psychedelic drugs, Psilocybin, Hallucinogen, N,N-Dimethyltryptamine, Psychedelic music, Cannabis and religion

BDSA projects that U.S. legal cannabis sales will approach USD 34 Billion by 2025, increasing at an 18% CAGR.

Key Points: 
  • BDSA projects that U.S. legal cannabis sales will approach USD 34 Billion by 2025, increasing at an 18% CAGR.
  • The most commonly used psychedelic compounds are psilocybin (originated in mushrooms), LSD (lysergic acid diethylamide), DMT (dimethyltryptamine), and mescaline.
  • Last year, the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine has been launched and attracted investors as well as private donors.
  • Developing PSYC into a trusted resource marketplace for medicinal psychedelics is a multi-stage project that we have just initiated.